This document is a comprehensive description of the rules surrounding the use of ISBT 128 as well as guidance in the interpretation of these rules. 

The purpose of this document is to provide standards and guidance for the coding and labeling of medical products of human origin (MPHO): blood, cellular therapy products, tissues, milk, and organs, as well as those plasma derivatives for which ABO is relevant.

The Standard Terminology document provides definitions to all ISBT 128 terminology. The document should be used in conjunction with the ISBT 128 Product Description Code Database.

The version number of the Standard Terminology document will coincide with the first two numbers of the version of the applicable ISBT 128 Product Description Code Database. For example, Version 7.88 of the Standard Terminology shall coincide with Version 7.88.x of the ISBT 128 Product Description Code Database.

This document is intended to help facilities and software developers design appropriate ISBT 128 labels for tissue products.

This document is intended to help facilities, label vendors, and software developers design appropriate ISBT 128 labels for cellular therapy products. Greater detail is given for labeling than that provided in the ISBT 128 Technical Specification.

This document is intended to help facilities, label vendors, and software developers design appropriate ISBT 128 labels for blood products.

This document is intended to help facilities and software developers design appropriate ISBT 128 labels for ocular tissue products. Greater detail is given for labeling than that provided in the ISBT 128 Technical Specification.